XENE Form 144: 3,750 RSU shares listed for resale

Morgan Stanley Wealth Management Canada Inc. filed a Form 144 notifying the sale of Common Shares tied to a Restricted share unit award vesting dated 03/12/2026 for 3,750 shares.

Accepted by SEC EDGAR 03/13/2026 - 07:51 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Morgan Stanley Wealth Management Canada Inc. filed a Form 144 notifying the sale of Common Shares tied to a Restricted share unit award vesting dated 03/12/2026 for 3,750 shares. The notice also lists a 03/10/2026 sale of 2,771 shares by Andrea DiFabio and a reported figure 166,559 appearing in the securities block.

Insights

Securities Compliance Counsel

Form 144 records proposed resale of vested RSUs and recent sales by a holder.

The filing lists 3,750 common shares tied to a "Restricted share unit award vesting" on 03/12/2026. That phrase is the operative qualifier for the securities being offered for sale.

It also records a sale of 2,771 common shares on 03/10/2026 by Andrea DiFabio. Cash‑flow treatment and who receives proceeds are not stated in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does XENE's Form 144 disclose about the 3,750 shares?

The Form 144 lists 3,750 common shares tied to a "Restricted share unit award vesting" dated 03/12/2026. This identifies the source of the shares as vested RSUs rather than open‑market purchases or other issuances.

Who sold shares within the past three months according to the filing for XENE?

The filing shows Andrea DiFabio sold 2,771 common shares on 03/10/2026. The entry appears in the "Securities Sold During The Past 3 Months" section with an associated numeric entry of 166,559 in the securities block.

Does the Form 144 state how proceeds will be used for XENE securities?

The excerpt does not state a use of proceeds. It records the security type, source (RSU vesting), dates (03/12/2026, 03/10/2026) and share counts (3,750, 2,771) but contains no proceeds allocation or recipient details.

Which entity submitted the Form 144 filing related to XENE shares?

The filer listed is Morgan Stanley Wealth Management Canada Inc. with an address entry in Calgary and the securities are identified as Common Shares trading on NASDAQ in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001880129
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Xenon Pharmaceuticals Inc.
SEC File Number	001-36687
Address of Issuer	3650 Gilmore Way Burnaby BRITISH COLUMBIA, CANADA V5G 4W8
Phone	(604)-484-3300
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER JOHN KENNEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Morgan Stanley Wealth Management Canada Inc. Suite 1500, 600 - 3 Avenue SW Calgary Z4 T2P 0G5	1410	77867	83190316	03/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	03/12/2026	Restricted share unit award vesting	Issuer			3750	03/12/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andrea DiFabio 3650 Gilmore Way Burnaby A1 V5G 4W8	Common Shares	03/10/2026	2771	166559

144: Remarks and Signature

Remarks	The Common Shares reported on this Form 144 were obtained via the vesting of a restricted share unit award on March 12, 2026, and are being sold pursuant to a Rule 10b5-1 trading arrangement in the form of a durable sell-to-cover instruction.
Date of Notice	03/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Kenney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)